Enhanced Integrated Liquid Flow Closed Loop Sensing and Control

Publication ID: 24-11857762_0006_PTD
Published: November 07, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Integrated Liquid Flow Closed Loop Sensing and Control,” Published Technical Disclosure No. 24-11857762_0006_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857762_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,762.

Summary of the Inventive Concept

An improved system for infusion fluid flow monitoring and control, integrating real-time flow rate measurement and feedback to optimize infusion pump performance, ensuring safer and more efficient fluid administration.

Background and Problem Solved

The original patent disclosed an integrated liquid flow closed loop sensing and control system, but it had limitations in terms of real-time flow rate measurement and feedback. The new inventive concept addresses these limitations by incorporating advanced electronic flow sensors and control circuitry to provide real-time flow rate data and adjust the infusion pump's flow rate accordingly, ensuring more accurate and efficient fluid administration.

Detailed Description of the Inventive Concept

The enhanced system comprises an IV administration set with an integrated electronic flow sensor, which measures fluid flow rate in real-time and provides feedback to an infusion pump. The control circuitry adjusts the infusion pump's flow rate based on the real-time measurements, ensuring accurate and efficient fluid administration. The system can also transmit real-time flow rate data to a remote monitoring system, enabling medical staff to monitor and respond to flow rate deviations. The integrated flow sensor and control circuitry can be configured to provide alerts to medical staff in case of flow rate deviations, ensuring timely intervention.

Novelty and Inventive Step

The new claims introduce the concept of real-time flow rate measurement and feedback, which is not present in the original patent. The integration of electronic flow sensors and control circuitry to adjust the infusion pump's flow rate based on real-time measurements is a novel and non-obvious improvement over the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different types of flow sensors, such as ultrasonic or coriolis flow sensors, or the integration of additional sensors to measure other parameters, such as fluid pressure or temperature. The system could also be configured to work with different types of infusion pumps or to provide real-time data to different types of remote monitoring systems.

Potential Commercial Applications and Market

The enhanced system has significant commercial potential in the medical device industry, particularly in the field of infusion therapy. The ability to provide real-time flow rate measurement and feedback can improve patient safety and reduce the risk of medication errors. The system can be marketed to hospitals, clinics, and other healthcare facilities, as well as to medical device manufacturers and distributors.

CPC Classifications

SectionClassGroup
A A61 A61M5/172
A A61 A61M2205/3334
A A61 A61M2205/3584
A A61 A61M2205/52
H H01 H01R13/15
H H01 H01R2201/12
H H01 H01R2201/20
H H02 H02J50/10

Field of Art

Medical device engineering, specifically intravenous (IV) administration systems and fluid flow control technologies, involving biomedical instrumentation, sensor integration, and medical device communication protocols

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in medical device design, fluid sensing technologies, electronic control systems, and medical instrumentation, typically holding a master's degree with 3-5 years of experience in medical device development

Obviousness Rationale

A PHOSITA would recognize that integrating real-time flow sensing and adaptive control mechanisms into an existing IV administration set represents a predictable engineering improvement. The source patent's foundational design provides a clear framework for incorporating advanced sensing and feedback technologies. The proposed variations represent logical extensions of existing medical device control principles, utilizing standard sensor integration and communication techniques.

Obvious Combinations & Variations

Source Patent Element
Flow stop mechanism with tubing fitment and housing for controlling fluid flow
PTD Variation
Adding electronic flow sensor with real-time measurement capabilities integrated into the flow stop housing
Obviousness Reasoning
Adding electronic sensing to an existing mechanical flow control mechanism is a known technique in medical device design, representing a predictable improvement in monitoring and control functionality
Source Patent Element
Control circuitry configured to send control signals to modify infusion device flow rate
PTD Variation
Implementing adaptive feedback loop where flow sensor data dynamically adjusts pump flow rate in real-time
Obviousness Reasoning
Creating closed-loop control systems with sensor-driven adjustments is a standard engineering approach for improving precision and reliability in medical device performance
Source Patent Element
Conductive connections using pogo pin connectors or elastomeric plastic conductors
PTD Variation
Extending data communication capabilities to transmit real-time flow rate data to remote monitoring systems
Obviousness Reasoning
Expanding data communication capabilities using existing connector technologies represents a straightforward design evolution driven by increasing demand for remote patient monitoring
Source Patent Element
IV administration set with basic flow control mechanisms
PTD Variation
Adding alert generation for medical staff when flow rate deviations occur
Obviousness Reasoning
Implementing safety monitoring and alert systems is a predictable enhancement in medical device design, driven by patient safety considerations and standard medical technology development practices
Source Patent Element
Basic fluid flow sensing in IV administration set
PTD Variation
Introducing alternative sensor technologies like ultrasonic or coriolis flow sensors
Obviousness Reasoning
Exploring alternative sensor technologies within a known application domain represents an obvious design exploration for a PHOSITA seeking improved measurement precision
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857762 and the disclosed technical variations, a person having ordinary skill in the art would find the proposed improvements in integrated IV administration set sensing and control technologies to be obvious and non-patentable. The incremental advancements in real-time flow monitoring, adaptive control mechanisms, and remote data transmission represent predictable engineering solutions within the established technological framework of medical fluid delivery systems.

Original Patent Information

Patent NumberUS 11,857,762
TitleIntegrated liquid flow closed loop sensing and control
Assignee(s)CareFusion 303, Inc.